Top compounds associated with response to HSFX2


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib gCSI pan-cancer AAC -0.026 0.6
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.6
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.017 0.6
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.6
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.018 0.6
mRNA ML210 CTRPv2 pan-cancer AAC 0.016 0.6
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.6
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.017 0.7
mRNA clofarabine CTRPv2 pan-cancer AAC -0.013 0.7
mRNA procarbazine CTRPv2 pan-cancer AAC -0.018 0.7
Download CSV